M Aylward, R J Parker, J Maddock. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAllyl Compounds/administration & dosageAllyl Compounds/therapeutic useArthritis, Rheumatoid/drug therapyArthritis, Rheumatoid/immunologyArthritis, Rheumatoid/physiopathologyAspirin/administration & dosageAspirin/therapeutic useBlood SedimentationClinical Trials as TopicFemaleHumansImmunoglobulin A/analysisImmunoglobulin G/analysisImmunoglobulin M/analysisMaleMiddle AgedPain ManagementPhenyl Ethers/administration & dosagePhenyl Ethers/therapeutic usePhenylacetates/administration & dosagePhenylacetates/therapeutic usePlacebosRheumatoid Factor/analysis
Substances: See more » Allyl CompoundsImmunoglobulin AImmunoglobulin GImmunoglobulin MPhenyl EthersPhenylacetatesPlacebosRheumatoid FactorAspirin
Year: 1974 PMID: 4602026 PMCID: PMC1006254 DOI: 10.1136/ard.33.3.268
Source DB: PubMed Journal: Ann Rheum Dis ISSN: 0003-4967 Impact factor: 19.103